Ayurvedic Management of Ardhavbhedaka(Migraine)-A Case Study

Chandra Shekhar Singh; Uttara Kumar Chaturvedi

doi:10.48165/

Authors

Chandra Shekhar Singh PG Scholar department of Panchakarma , National Institute of Ayurveda, Deemed to be university, Jaipur, Rajasthan, India Author
Uttara Kumar Chaturvedi PG Scholar department of Panchakarma , National Institute of Ayurveda, Deemed to be university, Jaipur, Rajasthan, India Author

DOI:

https://doi.org/10.48165/

Keywords:

Migraine, Ardhavbhedaka, Sarvang Abhyang, Swedan, Mustyadi Yapana Basti

Abstract

Migraine is a frequent brain illness that can be debilitating. Chronic migraine (CM) is defined as 15 headache days per month, whereas episodic migraine (EM) is defined as 15 headache days per month. According to the World Health Organization (WHO), 3000 migraine attacks occur daily for every million people. When the quality of life is seriously impacted by migraine, prophylactic medication treatment should be explored. Migraine can be clinically correlated with Ardhavbhedaka. In present case study the patient of Ardhavabhedaka was treated with Sarvang Abhyang, Swedan, Mustyadi Yapana Basti and Shaman Chikitsa. We selected the drugs for shaman Chikitsa Shudh Tankan Bhasm, Sphatika Bhasma, Lodhra Churna, Nagkesar Churmna, Lodhra Asaav ,Tab Vingrai, Syp M Shankhpuspi and Smritisagar ras were used. There was a significant reduction in symptoms in the patient. The patient experienced complete relief from migraine symptoms after undergoing all of the aforementioned treatments. After 3 months, the patient was followed up on, and there had been no recurrence of symptoms or ill effects from the therapy.

Downloads

Download data is not yet available.

References

Leonardi M, Steiner TJ, Scher AT, Lipton rb. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005 Dec;6(6):429-40. Epub 2005 Dec 15.

Lyngberg AC, rasmussen BK, Jorgensen T, et al. Inci dence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol 2005; 161(11):1066- 73

Stovner L, Hagen K, Jensen r, et al. The global burden of headache documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27(3): 193- 210

Stewart WF, Linet MS, Celentano DD, et al. Age- and sex specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991;134 (10):1111-20

Abu-Arefeh I, russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1994; 309(6957):765- 9. 6. Bigal ME, Liberman JN, Lipton rB, et al. Age- dependent prevalence and clinical features of migraine. Neurology 2006; 67(2):246-51.

Acharya YT, Sushruta Samhita of Sushruta with Nibandhsangraha Commentry of Dalhana Acharya, Uttartantra. 3rd ed., Ch.25, Ver.15-16. Varanasi: Chaukhambha Surbharati Prakashan; 2014.

Acharya YT, ed. Charak Samhita of Ag- nivesha with Ayurveda Dipika commentary of Chakra- panidatta, Siddhisthana. Ch. 9, Ver.75, Reprint edition. Varanasi:Chaukhambha Prakashan;2011.

https://www.ijrams.com/uploads/185/6749_pdf.pdf 10. Chaudhari, V., Rajagopala, M., Mistry, S., & Vaghela, D. B. (2010). Role of Pradhamana Nasya and Trayodashanga Kwatha in the management of Dushta Pratishyaya with special reference to chronic sinusitis. Ayu, 31(3), 325–331. https://doi.org/10.4103/0974-8520.77165

https://www.ayurtimes.com/godanti-bhasma-benefits medicinal-uses-dosage-side-effects/

https://www.sciencedirect.com/science/article/pii/S09759 47616300456